Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Tokyo, Japan
Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Cancer Institute New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Apulia, Italy
  • Azienda ospedaliera oo rr di foggi; Hematology Foggia, Apulia, Italy
  • Irccs Crob Rionero in Vulture, Basilicate, Italy
  • Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy
View all 39 locations